Newsletter Subject

3 Potential Coronavirus Research Breakthroughs That Could Help End the Pandemic

From

inhresearch.com

Email Address

mail@inhresearch.com

Sent On

Wed, Apr 15, 2020 04:19 PM

Email Preheader Text

Medical science is making encouraging inroads against COVID-19. Medical science is making encouragin

Medical science is making encouraging inroads against COVID-19. Medical science is making encouraging inroads against COVID-19. [Health Watch] Sponsored Content New 5-min deep sleep trick. No pills. [Have you seen this](? The image below proves without a doubt that you can calm your busy mind and fall asleep in minutes without dangerous sleep aids of any kind... Scientists at Harvard and Penn State showed that playing specific sounds can slow brainwaves from short and frantic… To the long and relaxed waves found during the deepest stages of sleep. And after years of research, you can now use [this simple technique]( to fall asleep in as little as 5 minutes… Stay asleep for hours longer than normal…And wake up feeling more refreshed than you have in years. [Click here]( --------------------------------------------------------------- 3 Potential Coronavirus Research Breakthroughs That Could Help End the Pandemic We sit at home and wait. We watch friends, family, and the famous fall ill. And still we wait. As coronavirus spreads, the world is impatiently anticipating a medical game changer...something that will reliably cure or prevent COVID-19. Something that will allow us to get back to normal. Two drugs used to treat malaria and lupus, hydroxychloroquine and chloroquine, have gotten a lot of media attention as potential COVID-19 treatments. There have been small studies from China and France that show the drugs help some patients. But the medications have not been thoroughly tested. None of the trials were placebo controlled. So there’s no way to know if the patients who took them would have gotten better without the drugs, or perhaps even improved faster. Nor were the studies reviewed by independent researchers, as is routine for high-quality trials. The professional organization that published the positive French study recently rescinded its approval. The International Society of Antimicrobial Chemotherapy said, “The article does not meet the society’s expected standard.” Hydroxychloroquine and chloroquine also have serious side effects. Most alarming is the fact that they can affect the heart. Hydroxychloroquine can cause heart arrhythmias. Some hospitals in Sweden stopped providing hydroxychloroquine to treat the coronavirus after reports of adverse side effects, according to Swedish news media. The two drugs might be effective. They might not be. At this point, we just don’t know. But they aren’t the only game in town. New research suggests there are at least three potential breakthroughs that show as much if not more promise for addressing the coronavirus crisis: - The Seattle vaccine. This was the first potential coronavirus vaccine out of the gate. It’s being tested at Seattle’s Kaiser Permanente Washington Health Research Institute. It’s still in its initial phase, which will determine if it is safe. Dr. Anthony Fauci, the institute’s director, said the study was “an important first step” and was “launched in record speed.” The researchers were able to get a running start by building on knowledge from the SARS and MERS outbreaks. Both are forms of coronavirus. This vaccine, which is being developed by Moderna Therapeutics, is a “nucleic acid vaccine.” That means it uses genetic material—RNA—to enable the immune system to identify and fight the coronavirus. This technique has previously been used in veterinary medicine, but never before in humans. The advantage of an RNA vaccine is that it can be produced quickly. Moderna is already buying more equipment so they’ll be ready to produce millions of doses if it proves safe and effective. The Seattle vaccine won’t be ready for large scale immunizations for at least a year. That’s much faster than it usually takes to develop new vaccines. The process often takes 10 to 15 years. --------------------------------------------------------------- Recommended Content Bizarre crystals help slash heart attack risk nearly in HALF These [bizarre crystals]( help slash heart attack risk nearly in HALF. This natural heart “armor” can keep plaque out of arteries. [magnesium]( Just a tiny amount helps slash our risk of cardiac death by a whopping 41%...imagine what more could do. Discover how you can protect your hard-working heart by [clicking here](. [Click here]( --------------------------------------------------------------- - The Pittsburgh vaccine. Researchers at the University of Pittsburgh School of Medicine recently announced that they have successfully tested a coronavirus vaccine in mice. How soon before human trials? Study co-author Professor Louis D. Falo said, “We would like to think a month, give or take.” The vaccine consists of lab-created coronavirus proteins. Once exposed to them, the immune system learns to recognize and attack the virus. Professor Falo explained that this vaccine has a unique delivery system. It would be given to humans using a tiny patch of “microneedles.” These consist of viral proteins and sugar. The microneedles reach the bloodstream after dissolving into the skin. Unlike other vaccines, this one wouldn’t need refrigeration. That’s a big plus, according to Dr. Bruce Y. Lee. He’s an expert on pandemic response. He said not requiring refrigeration makes a vaccine easier to mass produce and distribute. “It’s a huge undertaking to vaccinate a large population as quickly as possible,” said Dr. Lee. The Pittsburgh researchers hope to get FDA permission to begin human testing in the next few months. The vaccine could be ready in 18 months or less. - Blood plasma treatment. If there’s one thing we could desperately use other than a vaccine, it’s an effective treatment. In the days before vaccines, “convalescent serums” were used against a number of infectious diseases, including the 1918 Spanish flu pandemic. The method is simple: Blood plasma from people who have survived a particular infectious disease is injected into others who are suffering from the same illness. The blood plasma contains antibodies that were generated to target the disease. The treatment has rarely been used in the U.S. in recent decades. But it helped patients recover during the 2002 SARS outbreak. “It’s a stopgap measure we can put in place quickly,” said Dr. Jeffrey Henderson of Washington University School of Medicine. It’s not a cure, “but rather a way to reduce the severity of illness.” Former COVID-19 patients in New York and Houston have already donated plasma to generate serums. Hospitals and blood centers are preparing for donations from hundreds more. The Mayo Clinic will lead a national coronavirus serum study. The American Red Cross will head the effort to collect and distribute the plasma. Dr. Arturo Casadevall is an infectious disease expert at the Johns Hopkins Bloomberg School of Public Health. He said that until vaccines are ready, a serum “might be our best option.” Editor’s Note: Discover the single best supplement for stronger immunity... The fruit extract that helps 93% of people with respiratory viruses get better in just two days... The germ hotspot that most of us forget to sanitize. Find all this and more is in Independent Healing's Coronavirus Pandemic Guide. Go [HERE](. In Good Health, Garry Messick Managing Editor The Institute for Natural Healing [References Available Here.]( Related Articles: [Coronavirus Stress: 5 Ways to Keep Calm and Carry On]( [9 Coronavirus Symptoms You Should Watch For]( [Coronavirus: 8 Dos and Don’ts for Social Distancing]( --------------------------------------------------------------- //click2.inhresearch.com/t/EA/V-Y/x2M/ACWS8w/iBo/AAsy8g/AQ/-bvn © 2020 The Institute for Natural Healing. All Rights Reserved. For more from The Institute for Natural Healing, [visit our website](. To end your free subscription, click here: [Unsubscribe]( Health Watch may be republished with its links intact by non-commercial entities. Health Watch may not be republished for commercial purposes without written permission. This information is offered as a general guideline, not one-size-fits-all medical advice. Talk to your doctor before making any changes in your personal health care regimen. To manage your subscription by mail or for any other subscription issues, write us at: Order Processing Center Attn: Customer Service P.O. Box 925 Frederick, MD 21705 USA

Marketing emails from inhresearch.com

View More
Sent On

11/08/2022

Sent On

11/08/2022

Sent On

11/08/2022

Sent On

10/08/2022

Sent On

10/08/2022

Sent On

09/08/2022

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.